Position in JNJ
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$4,431,268
+$13,749 QoQ
Shares Held
17,448
-3.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.88%
of 13F equity value
Holder Rank
#1,701
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Klingman & Associates, LLC holds $15,277,947 across 11 Drug Manufacturers - General names. JNJ ranks #1 (29.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
17,448 | $4,431,268 | |
| 2 | ABBV |
AbbVie Inc.
|
13,168 | $3,313,595 | |
| 3 | LLY |
ELI LILLY & Co
|
2,410 | $2,890,626 | |
| 4 | MRK |
Merck & Co., Inc.
|
10,463 | $1,344,495 | |
| 5 | AMGN |
Amgen Inc
|
2,140 | $774,936 | |
| 6 | NVS |
Novartis AG
|
4,523 | $708,844 | |
| 7 | PFE |
Pfizer Inc
|
28,237 | $679,946 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,664 | $336,569 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,431,268 | 17,448 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $4,417,519 | 18,072 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,682,054 | 17,792 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $3,263,577 | 17,601 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $2,788,909 | 18,258 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $2,816,626 | 16,984 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,166,262 | 14,979 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $2,481,948 | 15,315 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $2,207,162 | 15,101 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $2,480,261 | 15,679 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $2,480,880 | 15,828 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $2,470,039 | 15,859 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $2,671,658 | 16,141 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $2,680,105 | 17,291 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $3,094,024 | 17,515 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $2,819,756 | 17,261 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $3,127,193 | 17,617 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $3,147,782 | 17,761 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $2,231,608 | 13,045 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $2,082,542 | 12,895 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $2,102,906 | 12,765 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $2,348,890 | 14,292 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $2,044,051 | 12,988 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $1,531,677 | 10,288 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $1,288,592 | 9,163 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $1,162,205 | 8,863 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||